Although it has been reported that FAS also mediates non-apoptotic signaling pathways to promote tumor growth under certain cellular context [9], tumoral FAS expression plays a key role for CAR-T cell efficacy [10], and it alone predicts survival of chimeric antigen receptor (CAR)-T-treated patients in a large clinical trial [11]. This evidence concerns the gene FAS and neoplasm.